Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Nov;13(11):1640-6.
doi: 10.3201/eid1311.070674.

Growing problem of multidrug-resistant enteric pathogens in Africa

Affiliations
Review

Growing problem of multidrug-resistant enteric pathogens in Africa

Iruka N Okeke et al. Emerg Infect Dis. 2007 Nov.

Abstract

Control of fecal-orally transmitted pathogens is inadequate in many developing countries, in particular, in sub-Saharan Africa. Acquired resistance to antimicrobial drugs is becoming more prevalent among Vibrio cholerae, Salmonella enteritidis, diarrheagenic Escherichia coli, and other pathogens in this region. The poor, who experience most of the infections caused by these organisms, bear the brunt of extended illness and exacerbated proportion of deaths brought about by resistance. Improved antimicrobial drug stewardship is an often cited, but inadequately implemented, intervention for resistance control. Resistance containment also requires improvements in infectious disease control, access to and quality assurance of antimicrobial agents, as well as diagnostic facilities. Structural improvements along these lines will also enhance disease prevention and control as well as rational antimicrobial drug use. Additionally, more research is needed to identify low-cost, high-impact interventions for resistance control.

PubMed Disclaimer

Figures

Figure
Figure
Itinerant medicine vendor in Oja-tuntun marketplace, Ile-Ife, Nigeria.

Similar articles

Cited by

References

    1. Bates I, Fenton C, Gruber J, Lalloo D, Medina Lara A, Squire SB, et al. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. Lancet Infect Dis. 2004;4:267–77. 10.1016/S1473-3099(04)01002-3 - DOI - PubMed
    1. Schellenberg JA, Victora CG, Mushi A, de Savigny D, Schellenberg D, Mshinda H, et al. Inequities among the very poor: health care for children in rural southern Tanzania. Lancet. 2003;361:561–6. 10.1016/S0140-6736(03)12515-9 - DOI - PubMed
    1. Arrow K, Panosian C, Gelband H. Saving lives, buying time. Economics of malaria drugs in an age of resistance. Washington: National Academies Press; 2004. - PubMed
    1. Singh JA, Upshur R, Padayatchi N. XDR-TB in South Africa: no time for denial or complacency. PLoS Med. 2007;4:e50. 10.1371/journal.pmed.0040050 - DOI - PMC - PubMed
    1. Griffith DC, Kelly-Hope LA, Miller MA. Review of reported cholera outbreaks worldwide, 1995–2005. Am J Trop Med Hyg. 2006;75:973–7. - PubMed

MeSH terms

LinkOut - more resources